Muscle and neuronal autoantibody markers of thymoma: Neurological correlations

Annals of the New York Academy of Sciences

Volumn 998, Issue , 2003, Pages 359-361

  Vernino, Steven ^a   Lennon, Vanda A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autonomic; CRMP 5; Encephalitis; Myasthenia gravis; Potassium channel; Thymoma

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL ANTIBODY; CHOLINERGIC RECEPTOR; POTASSIUM CHANNEL;

AUTOIMMUNE DISEASE; AUTONOMIC NEUROPATHY; CONFERENCE PAPER; CORRELATION ANALYSIS; DISEASE MARKER; EVALUATION; HUMAN; HYPERACTIVITY; MUSCLE; MYASTHENIA GRAVIS; MYOSITIS; NERVE CELL; NEUROLOGIC EXAMINATION; PARANEOPLASTIC NEUROPATHY; PEMPHIGUS; SEROLOGY; THYMOMA; VITILIGO;

PEMPHIGUS;

EID: 0141839031     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1254.042     Document Type: Conference Paper

References (4)

1. SOUADJIAN, J.V. et al. 1974. The spectrum of diseases associated with thymoma. Arch. Intern. Med. 134: 374-379.
2. LEWIS, J.E. et al. 1987. Thymoma: a clinicopathologic review. Cancer 60: 2727-2743.
3. VERNINO, S. et al. 1999. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology 53(6): 1233-1239.
4. Yu, Z. et al. 2001. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann. Neurol. 49: 146-154.